Skip to main content
Log in

Assessing the value of interferons in hepatitis D

  • Newsletter Article
  • Published:
Inpharma Weekly

&

Chronic hepatitis D is frequently the most aggressive form of viral hepatitis. In approximately 15% of patients, rapid progression to cirrhosis is seen. As yet, there is no established effective treatment for hepatitis D, although interferon-α-2a may be a promising candidate. Recent data on the use of interferon and other agents in the management of hepatitis D, along with new studies on the diagnosis and pathogenesis of the condition, were presented at the 5th International Symposium on Hepatitis Delta Virus and Liver Disease [ Gold Coast, Australia; August 1995 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higgins, G. Assessing the value of interferons in hepatitis D. Inpharma Wkly. 1004, 13–14 (1995). https://doi.org/10.2165/00128413-199510040-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199510040-00027

Keywords

Navigation